Pharma Focus Asia

Meissner Corporation Invests US$250 million to Construct New Manufacturing Facility

Introduction:

Meissner Corporation plans to construct new manufacturing facility. The new facility will be loacted at Georgia, USA.

Features:

The new site will have various structures including state-of-the-art clean room facilities, laboratories, R&D and office space.

The facility is the second  manufacturing facility in the United States, comprising an ideal location with an incredible talent pool and a strong geographic location allowing to serve customers on the East Coast and on a global basis.

The new project will double the manufacturing footprint and is expected to create more than 1,700 new jobs in the next eight years including various positions for example technicians, scientists and engineers, as well as information technology and administrative positions

The contruction of the new facility is expected to start its operations in 2026.

Specifications:

Name

Meissner Corporation

Type

New Construction

Budget

US$250 million

Year

2026

magazine-slider-imageHexagon - Expert Insights WebinarMFA + MMA 20244th Annual Cleaning Validation 20242nd Annual Pharma Impurity Conclave 2024CPHI Korea 2024CHEMICAL INDONESIA 2024World Orphan Drug Congress Europe 2024INALAB 2024Thermo Fisher - Drug Discovery and the impact of mAbsAdvanced Therapies USA 2024ISPE Singapore Affiliate Conference & Exhibition 20242024 PDA Aseptic Manufacturing Excellence Conference2024 PDA Aseptic Processing of Biopharmaceuticals Conference